Two recent studies examine early characteristics and urate-associated mortality in gout.
References1. Li Y, Piranavan P, Sundaresan D, Yood RA. Clinical Characteristics of Early Onset Gout in Outpatient Setting [Abstract 2217]. Arthritis Rheumatol. 2018;70(suppl 10). Accessed October 24, 2018.2. Perez-Ruiz F, Richette P, Stack A, et al. Failure to Reach Serum Urate Target Is Associated with Elevated Mortality in Gout [Abstract 869]. Arthritis Rheumatol. 2018;70(suppl 10). Accessed October 24, 2018.This information is brought to you by Rheumatology Network and is not sponsored by, nor a part of, the American College of Rheumatology.
Two studies presented at the American College of Rheumatology (ACR 2018) annual meeting in Chicago, IL, address early characteristics and urate-associated mortality in gout. In the first study, Li and colleagues found that patients with gout who are younger than age 40 are less likely to achieve uric acid targets and may go undertreated.1 In the second study, Perez-Ruiz and fellow international researchers discovered that failure to reach serum urate levels of less than 6 mg/dL predicted mortality in patients with gout.2 Scroll through the slides for the details of the two studies and the take-home points for clinicians.